Cargando…

A review of the use of exemestane in early breast cancer

Exemestane is a third-generation aromatase inhibitor, which has proven to be a useful drug in the treatment of early stage breast cancer. Several clinical trials have been performed or are currently underway using exemestane as adjuvant therapy in postmenopausal women, which will be the indication r...

Descripción completa

Detalles Bibliográficos
Autor principal: Robinson, Andrew
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697518/
https://www.ncbi.nlm.nih.gov/pubmed/19436613